Phuong N. Huynh

Array ( [id] => 404552 [patent_doc_number] => 07288381 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-30 [patent_title] => 'Group 2 allergen specific IgE-Fabs and use thereof' [patent_app_type] => utility [patent_app_number] => 10/027725 [patent_app_country] => US [patent_app_date] => 2001-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7197 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/288/07288381.pdf [firstpage_image] =>[orig_patent_app_number] => 10027725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525514 [patent_doc_number] => 20020192634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'EG-VEGF nucleic acids and polypeptides and methods of use' [patent_app_type] => new [patent_app_number] => 10/027603 [patent_app_country] => US [patent_app_date] => 2001-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 46279 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192634.pdf [firstpage_image] =>[orig_patent_app_number] => 10027603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847714 [patent_doc_number] => 20030166881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Novel genes associated with allergic hypersensitivity and mast cell activation' [patent_app_type] => new [patent_app_number] => 10/005907 [patent_app_country] => US [patent_app_date] => 2001-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 22163 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166881.pdf [firstpage_image] =>[orig_patent_app_number] => 10005907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5985662 [patent_doc_number] => 20020098474 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Human short-chain dehydrogenase' [patent_app_type] => new [patent_app_number] => 10/006163 [patent_app_country] => US [patent_app_date] => 2001-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 20072 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20020098474.pdf [firstpage_image] =>[orig_patent_app_number] => 10006163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245114 [patent_doc_number] => 06676941 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-01-13 [patent_title] => 'Antibody conjugate formulations for selectively inhibiting VEGF' [patent_app_type] => B2 [patent_app_number] => 09/998831 [patent_app_country] => US [patent_app_date] => 2001-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 92060 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/676/06676941.pdf [firstpage_image] =>[orig_patent_app_number] => 09998831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 765541 [patent_doc_number] => 07008666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-07 [patent_title] => 'Method of inhibiting overactivity of phagocytes or lymphocytes in an individual' [patent_app_type] => utility [patent_app_number] => 09/991971 [patent_app_country] => US [patent_app_date] => 2001-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 3849 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/008/07008666.pdf [firstpage_image] =>[orig_patent_app_number] => 09991971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5786351 [patent_doc_number] => 20020159996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-31 [patent_title] => 'Use of CD23 antagonists for the treatment of neoplastic disorders' [patent_app_type] => new [patent_app_number] => 09/985646 [patent_app_country] => US [patent_app_date] => 2001-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22403 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20020159996.pdf [firstpage_image] =>[orig_patent_app_number] => 09985646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715861 [patent_doc_number] => 20030027209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Methods for producing and improving therapeutic potency of binding polypeptides' [patent_app_type] => new [patent_app_number] => 10/001202 [patent_app_country] => US [patent_app_date] => 2001-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19291 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027209.pdf [firstpage_image] =>[orig_patent_app_number] => 10001202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987337 [patent_doc_number] => 20020099017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Novel gene' [patent_app_type] => new [patent_app_number] => 10/032626 [patent_app_country] => US [patent_app_date] => 2001-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8052 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099017.pdf [firstpage_image] =>[orig_patent_app_number] => 10032626 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6782616 [patent_doc_number] => 20030064063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Fusion molecules and methods for treatment of immune diseases' [patent_app_type] => new [patent_app_number] => 10/000439 [patent_app_country] => US [patent_app_date] => 2001-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 33729 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20030064063.pdf [firstpage_image] =>[orig_patent_app_number] => 10000439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1387148 [patent_doc_number] => 06552174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-04-22 [patent_title] => 'Human MutT2 antibodies' [patent_app_type] => B2 [patent_app_number] => 09/974800 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12774 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/552/06552174.pdf [firstpage_image] =>[orig_patent_app_number] => 09974800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6541455 [patent_doc_number] => 20020110540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-15 [patent_title] => 'Disease prevention by reactivation of the thymus' [patent_app_type] => new [patent_app_number] => 09/976598 [patent_app_country] => US [patent_app_date] => 2001-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 18730 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20020110540.pdf [firstpage_image] =>[orig_patent_app_number] => 09976598 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 727397 [patent_doc_number] => 07041288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobulin E to its high affinity receptors' [patent_app_type] => utility [patent_app_number] => 09/974449 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 9827 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041288.pdf [firstpage_image] =>[orig_patent_app_number] => 09974449 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817828 [patent_doc_number] => 20030068786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Process for the production of egg yolk antibodies for organochlorine pesticides' [patent_app_type] => new [patent_app_number] => 09/973199 [patent_app_country] => US [patent_app_date] => 2001-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3130 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068786.pdf [firstpage_image] =>[orig_patent_app_number] => 09973199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6675002 [patent_doc_number] => 20030060605 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Ligand for herpes simplex virus entry mediator and methods of use' [patent_app_type] => new [patent_app_number] => 09/967604 [patent_app_country] => US [patent_app_date] => 2001-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 37069 [patent_no_of_claims] => 95 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060605.pdf [firstpage_image] =>[orig_patent_app_number] => 09967604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5968279 [patent_doc_number] => 20020090696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Treating neurological disorders using human apoptosis inhibiting protein' [patent_app_type] => new [patent_app_number] => 09/966561 [patent_app_country] => US [patent_app_date] => 2001-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13108 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090696.pdf [firstpage_image] =>[orig_patent_app_number] => 09966561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7349378 [patent_doc_number] => 20040047874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-11 [patent_title] => 'Inhibition of antigen presentation with poorly catabolized polymers' [patent_app_type] => new [patent_app_number] => 10/381855 [patent_app_country] => US [patent_app_date] => 2003-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5163 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20040047874.pdf [firstpage_image] =>[orig_patent_app_number] => 10381855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6692661 [patent_doc_number] => 20030040093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Platelet activating factor acetylhydrolase, and gene thereof' [patent_app_type] => new [patent_app_number] => 09/961253 [patent_app_country] => US [patent_app_date] => 2001-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5368 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040093.pdf [firstpage_image] =>[orig_patent_app_number] => 09961253 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1017827 [patent_doc_number] => 06890721 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-10 [patent_title] => 'Interleukin-1β converting enzyme like apoptotic protease-6' [patent_app_type] => utility [patent_app_number] => 09/961201 [patent_app_country] => US [patent_app_date] => 2001-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 22304 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/890/06890721.pdf [firstpage_image] =>[orig_patent_app_number] => 09961201 [rel_patent_id] =>[rel_patent_doc_number] =>)